144 related articles for article (PubMed ID: 10203595)
1. The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumors.
Nishioka A; Ohizumi Y; Lam GK; Pickles TA; Chaplin DJ; Ogawa Y; Inomata T; Yoshida S
Oncol Rep; 1999; 6(3):583-6. PubMed ID: 10203595
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
3. Biological effectiveness of fractionated dose of pions in microscopic SCCVII tumors: comparison between tumor control dose and tumor growth time assays.
Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
Jpn J Cancer Res; 1995 Jun; 86(6):600-6. PubMed ID: 7622425
[TBL] [Abstract][Full Text] [Related]
4. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
[TBL] [Abstract][Full Text] [Related]
6. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
Rojas A; Hirst VK; Calvert AS; Johns H
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
[TBL] [Abstract][Full Text] [Related]
7. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
9. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
Zheng H; Olive PL
Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.
van Laarhoven HW; Bussink J; Lok J; Punt CJ; Heerschap A; van Der Kogel AJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):310-21. PubMed ID: 15337570
[TBL] [Abstract][Full Text] [Related]
12. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
Fenton BM
Br J Cancer; 1995 May; 71(5):945-9. PubMed ID: 7734318
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.
Simon JM; Lartigau E; Guichard M
Radiother Oncol; 1993 Sep; 28(3):203-7. PubMed ID: 8255997
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.
Fenton BM; Lord EM; Paoni SF
Radiat Res; 2000 Jan; 153(1):75-83. PubMed ID: 10630980
[TBL] [Abstract][Full Text] [Related]
16. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.
Bussink J; Kaanders JH; Rijken PF; Peters JP; Hodgkiss RJ; Marres HA; van der Kogel AJ
Radiother Oncol; 1999 Feb; 50(2):173-84. PubMed ID: 10368041
[TBL] [Abstract][Full Text] [Related]
17. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats.
Braun RD; Lanzen JL; Turnage JA; Rosner G; Dewhirst MW
Radiat Res; 2001 May; 155(5):724-33. PubMed ID: 11302770
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic enhancement of tumor radiosensitization strategies.
Griffin RJ; Ogawa A; Williams BW; Song CW
Immunol Invest; 2005; 34(3):343-59. PubMed ID: 16136785
[TBL] [Abstract][Full Text] [Related]
19. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
Rojas A; Stratford MR; Bentzen SM; Denekamp J
Int J Radiat Biol; 2004 Jul; 80(7):499-506. PubMed ID: 15360088
[TBL] [Abstract][Full Text] [Related]
20. Middle dose rate irradiation in combination with carbogen inhalation selectively and more markedly increases the responses of SCCVII tumors.
Ono K; Masunaga S; Akuta K; Akaboshi M
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):81-5. PubMed ID: 8175449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
